// App-Quantinova.ai

2208 : Multiplatform Profiling Characterizes Functional Networks in Genomically Stable and Instable Chronic Lymphocytic Leukemia

Researchers

Presenter

  • Johannes Bloehdorn

Principal Investigators

  • Billy Michael Chelliah Jebaraj

  • Amaro Taylor-Weiner

  • Sandra Robrecht

  • Julia Krzykalla

  • Karlheinz Holzmann

  • Harvey Johnston

  • Tetyana Klymenko

  • Barbara Eichhorst

  • Ru-Fang Yeh

  • Martin Weisser

  • Jennifer Edelmann

  • Kirsten Fischer

  • John G. Gribben

  • Dan A. Landau

  • Donna S. Neuberg

  • Mark S Cragg

  • Axel Benner

  • Michael Hallek

  • Catherine J. Wu

  • Hartmut Dhner

  • Stephan Stilgenbauer

  • Daniel Mertens

Medical Centers

  • Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany

  • Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Broad Institute of MIT and Harvard, Cambridge, MA

  • Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, University of Cologne, Cologne, Germany

  • Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany

  • Genomics Core Facility, Ulm University, Ulm, Germany

  • Cancer Research UK/NIHR Experimental Cancer Medicines Centre, University of Southampton,Southampton,United Kingdom

  • Sheffield Hallam University, Sheffield, United Kingdom

  • Nonclinical Biostatistics, Genentech, Inc., South San Francisco, CA

  • Roche Innovation Center Penzberg, Roche Pharmaceutical Research and Early Development, Penzberg, Germany

  • Division of Hematology/Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY

  • New York Genome Center, New York, NY

  • Department of Imaging, Dana-Farber Cancer Institute, Boston, MA

  • Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom

  • Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA

  • Department of Medicine, Brigham and Women's Hospital, Boston, MA

  • Harvard Medical School, Boston, MA

  • German Cancer Research Centre, Heidelberg, Germany

Locations

  • Germany

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • Cluster of Differentiation 19

  • Granulin precursor

  • Immunoglobulin heavy-chain variable region gene

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved